A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00520832

Enrollment

Registered

2007-08-27

Start date

2007-09-30

Completion date

2007-12-31

Last updated

2008-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Insomnia

Keywords

Primary Insomnia, Microcurrent Therapy, Sleep Surveys

Brief summary

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia. The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Interventions

DEVICEMicrocurrent

20 minutes of sub-threshold microcurrent 2 hours before bedtime per day for 21 days.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Student, Faculty or Staff * Age 18 - 40 * Symptoms of primary insomnia

Exclusion criteria

* No implanted electric devices * No local infection, injury or malignancy * No history of seizure or other neurological disorders * No current use of prescription or other substances that could effect sleep quality or quantity * Pregnancy

Design outcomes

Primary

Measure	Time frame
Pittsburgh Sleep Quality Index (PSQI)	—
Epworth Sleepiness Scale	—
Insomnia Severity Index	—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026